Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hypersensitivity Reaction

  Free Subscription


01.01.2024

5 Allergy
14 Allergy Asthma Proc
6 Ann Allergy Asthma Immunol
1 Br J Dermatol
3 Contact Dermatitis
3 Eur Respir J
1 J Allergy Clin Immunol
1 J Am Acad Dermatol
1 J Asthma
1 J Dermatol
1 J Invest Dermatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy


  1. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 9-11 June, 2023.
    Allergy. 2023;78 Suppl 112:3-682.
    PubMed        

  2. GEISSLER N, Orola M, Alinaghi M, Nardo A, et al
    Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance.
    Allergy. 2023 Dec 27. doi: 10.1111/all.15989.
    PubMed        

  3. HAMELMANN E, Hammerby E, Scharling KS, Pedersen M, et al
    Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15985.
    PubMed         Abstract available

  4. CAMINATI M, Buhl R, Corren J, Hanania NA, et al
    Tezepelumab in patients with allergic and eosinophilic asthma.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15986.
    PubMed         Abstract available

  5. LEE E, Rhee EH, Yu J, Kim K, et al
    Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID-19 pandemic.
    Allergy. 2023 Dec 23. doi: 10.1111/all.15992.
    PubMed        


    Allergy Asthma Proc

  6. TACHDJIAN R, Savic S, Fridman M, Frade JP, et al
    Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks.
    Allergy Asthma Proc. 2024;45:37-43.
    PubMed         Abstract available

  7. MAGEN E, Merzon E, Green I, Golan-Cohen A, et al
    A case-control study for comorbidity and laboratory factors associated with food-induced anaphylaxis.
    Allergy Asthma Proc. 2024;45:53-60.
    PubMed         Abstract available

  8. ARIKOGLU T, Tokmeci N, Demirhan A, Kont Ozhan A, et al
    Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate subgroup.
    Allergy Asthma Proc. 2024;45:14-23.
    PubMed         Abstract available

  9. HODGES M, Freigeh GE, Troost J, Baptist AP, et al
    Assessment of mask use on oxygen saturation in adults and children with asthma.
    Allergy Asthma Proc. 2024;45:24-32.
    PubMed         Abstract available


  10. Abstracts presented at the Eastern Allergy Conference June 1-4, 2023, Palm Beach, Florida.
    Allergy Asthma Proc. 2024;45:75-78.
    PubMed        

  11. REBROVA S, Emelyanov A, Sergeeva G, Korneenkov A, et al
    Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis.
    Allergy Asthma Proc. 2024;45:e9-e13.
    PubMed         Abstract available

  12. NELSON HS, Bernstein DI, Biedermann T, Nolte H, et al
    Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.
    Allergy Asthma Proc. 2024;45:33-36.
    PubMed         Abstract available

  13. BOURGOYNE K, Sampognaro L, Bhat A, Valdes Camacho J, et al
    Health disparities in hymenoptera venom allergy management.
    Allergy Asthma Proc. 2024;45:50-52.
    PubMed         Abstract available

  14. SHIM JS, Kim MH, Cho YJ
    Risk of asthma and/or wheezing in obese individuals with or without metabolic syndrome: From the Korea National Health and Nutrition Examination Survey data.
    Allergy Asthma Proc. 2024;45:e1-e8.
    PubMed         Abstract available

  15. CHEN X, Luo H, Yan W, Tang K, et al
    Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort.
    Allergy Asthma Proc. 2024;45:e14-e22.
    PubMed         Abstract available

  16. LUNDBERG M, Maurer R, Tchekmedyian R, Mullur J, et al
    Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population.
    Allergy Asthma Proc. 2024;45:5-13.
    PubMed         Abstract available

  17. LIM PPC, Moore LN, Minich NM, Wessell KR, et al
    Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
    Allergy Asthma Proc. 2024;45:61-69.
    PubMed         Abstract available

  18. LUMRY WR, Bernstein JA, Li HH, Levy DS, et al
    An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.
    Allergy Asthma Proc. 2024;45:44-49.
    PubMed         Abstract available

  19. BELLANTI JA, Settipane RA
    Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs.
    Allergy Asthma Proc. 2024;45:1-4.
    PubMed        


    Ann Allergy Asthma Immunol

  20. MARSHALL HF, Leung DYM, Lack G, Sindher S, et al
    Topical steroid withdrawal and atopic dermatitis.
    Ann Allergy Asthma Immunol. 2023 Dec 22:S1081-1206(23)01507.
    PubMed        

  21. SAMYNATHAN A, Silverberg JI
    Navigating the Atopic Dermatitis Toolbox: Challenging Scenarios and Shared Decision Making.
    Ann Allergy Asthma Immunol. 2023 Dec 23:S1081-1206(23)01505.
    PubMed         Abstract available

  22. RAVIKUMAR R, Arora NS, Hanson R, Barhitte L, et al
    A novel two-step process for the management of inpatient beta-lactam allergy labels.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01512.
    PubMed         Abstract available

  23. BARTOLOME-ZAVALA B, Estrada-Rodriguez JL, Diaz-Golpe V
    Occupational Hops Allergy with non-specific Lipid-Transfer-Protein sensitization: cross-reactivity with food non-specific Lipid-Transfer-Protein.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01513.
    PubMed        

  24. MONAHAN R, Alfaro E, Ho H, Otani IM, et al
    Hereditary Alpha Tryptasemia Presenting as Recurrent Chemotherapy Hypersensitivity Reactions.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01506.
    PubMed        

  25. HO CH, Lee HJ, Yeh YH, Gau CC, et al
    Physician adherence to anaphylaxis guidelines among different age groups in emergency departments: 20-year observational study.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01511.
    PubMed         Abstract available


    Br J Dermatol

  26. JOHNSON C, Smith P, Haran K, Kranyak A, et al
    Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'.
    Br J Dermatol. 2023 Dec 27:ljad529. doi: 10.1093.
    PubMed        


    Contact Dermatitis

  27. TRIMECHE K, Lahouel I, Belhadjali H, Salah NB, et al
    Contact allergy in atopic dermatitis: A prospective study on prevalence, incriminated allergens and clinical insights.
    Contact Dermatitis. 2023 Dec 27. doi: 10.1111/cod.14494.
    PubMed         Abstract available

  28. HUANG C, Chiang SYV, Gawkrodger DJ
    The contribution of metal allergy to the failure of metal alloy implants, with special reference to titanium: Current knowledge and controversies.
    Contact Dermatitis. 2023 Dec 26. doi: 10.1111/cod.14481.
    PubMed         Abstract available

  29. BRUZE M, Isaksson M, Svedman C, Engfeldt M, et al
    Occlusion of sensitizers in the baseline series for 48 h detects more contact allergy than occlusion for 24 h.
    Contact Dermatitis. 2023 Dec 26. doi: 10.1111/cod.14484.
    PubMed        


    Eur Respir J

  30. WECKMANN M, Reddy KD
    Epigenome-wide association studies: the exposures of yesterday form the methylations of tomorrow.
    Eur Respir J. 2023;62:2301552.
    PubMed        

  31. CIVIDINI S, Sinha I, Donegan S, Maden M, et al
    Best step-up treatments for children with uncontrolled asthma: A systematic review and network meta-analysis of individual participant data.
    Eur Respir J. 2023 Nov 9:2301011. doi: 10.1183/13993003.01011-2023.
    PubMed         Abstract available

  32. HERRERA-LUIS E, de la Rosa-Baez C, Huntsman S, Eng C, et al
    Novel insights into the whole blood DNA methylome of asthma in ethnically diverse children and youth.
    Eur Respir J. 2023 Oct 6:2300714. doi: 10.1183/13993003.00714-2023.
    PubMed         Abstract available


    J Allergy Clin Immunol

  33. HILS M, Hoffard N, Iuliano C, Kreft L, et al
    IgE and anaphylaxis specific to the carbohydrate alpha-gal depend on interleukin-4.
    J Allergy Clin Immunol. 2023 Dec 20:S0091-6749(23)02453.
    PubMed         Abstract available


    J Am Acad Dermatol

  34. MEROLA JF, Ertmer B, Liang H, Yue X, et al
    Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.
    J Am Acad Dermatol. 2023 Dec 24:S0190-9622(23)03400.
    PubMed         Abstract available


    J Asthma

  35. COLQUE-BAYONA M, Hernandez-Cano N, Tomas-Perez M, Caballero T, et al
    Global Influence of Dupilumab on Quality of Life in a Severe Asthma Patient with T2 Multimorbidities: A Case Report on Atopic Dermatitis, Chronic Rhinosinusitis with Nasal Polyposis, and Eosinophilic Esophagitis.
    J Asthma. 2023 Dec 28:1-11. doi: 10.1080/02770903.2023.2300712.
    PubMed         Abstract available


    J Dermatol

  36. MASUDA T, Yonekura S, Kataoka K, Mizoguchi K, et al
    Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment.
    J Dermatol. 2023 Dec 27. doi: 10.1111/1346-8138.17085.
    PubMed        


    J Invest Dermatol

  37. NAKAI S, Kume M, Matsumura Y, Koguchi-Yoshioka H, et al
    CD69 is indispensable for the development of functional local immune memory in murine contact hypersensitivity.
    J Invest Dermatol. 2023 Dec 20:S0022-202X(23)03190.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.